COMP <GO>
MET vs JPM // EV/EBITDA & P/E VALUATION
MetLife Inc. (NYSE) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: MET 8
— JPM 6
▲ EV/EBITDA & P/E VALUATION LEADER: JPM
LAST: $100.02 (-0.80%) • MKT CAP: $64.08B
valuation
55.0x
LAST: $337.04 (-1.90%) • MKT CAP: $895.92B
valuation
9.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MET VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MET | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.60% | 17.37% | -15.77 | JPM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 55.0x | 9.7x | +45.33 | JPM | /valuation <GO> |
| Free Cash Flow Yield | 22.00% | -18.14% | +40.14 | MET | /fcf-yield <GO> |
| Operating Margin | 75.00% | 42.07% | +32.93 | MET | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 32.63% | +35.37 | MET | /net-margins <GO> |
| Revenue Growth (YoY) | 8.50% | 13.53% | -5.03 | JPM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.36% | 1.96% | +0.40 | MET | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 0.37 | +0.08 | MET | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 2/9 | +5.00 | MET | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 4.84% | +2.56 | JPM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.1 | 49.0 | +4.01 | MET | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 1.00 | +0.16 | MET | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.8x | 13.6x | +5.23 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $64.08B | $895.92B | -$831.84B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MET REV | JPM REV | MET GROSS % | JPM GROSS % | MET FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.44B | $182.45B | 44.0% | — | $16.98B | -$147.78B |
| FY 2024 | $2.25B | $177.56B | 44.0% | — | $14.50B | -$42.01B |
| FY 2023 | $2.23B | $158.10B | 44.0% | — | $13.62B | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MET // BETA 1.16
JPM // BETA 1.00